– CANADA, Vancouver – RavenQuest BioMed Inc. (CSE: RQB | OTCQB: RVVQF | FRA:1IT), one of Canada’s most innovative cannabis companies, today announced that Mark Percival and Mark Ahrens-Townsend have been elected as directors of the Company at its annual general meeting held on October 30, 2019.
“As RavenQuest continues to lead the industry as an innovator among cannabis companies, it is important that the composition, experience and expertise of our board continue to align with the Company’s strategic direction,” said George Robinson, CEO of RavenQuest.
“I’m confident that the changes announced today will ensure our board will continue to provide robust oversight and leadership as we embark upon the production era of our growing company,” Robinson continued.
Mrs. Percival and Ahrens-Townsend fill the vacancies created by Chris Bechtel and Dr. Jorge Bonet, who did not stand for re-election at the meeting.
“RavenQuest wishes to thank Mr. Bechtel and Dr. Bonet for their contribution to the Company. During our early days as a public entity, both gentlemen were key contributors in guiding our company through the many accomplishments it has made to this point,” stated Robinson.
About Mark Percival
Dr. Mark Percival is the CEO of Nanosphere Health Sciences Inc. and the owner of Health Coach Systems International Inc. He has been a progressive health professional and clinician for 33 years. He has also been a corporate executive and co-founder of seven companies in the healthcare industry over the last 24 years. His experience compelled him to create the first health coach company, Health Coach Systems International Inc. Founded in the late 80’s, Health Coach continuously challenged the status quo in healthcare. Mark’s leadership and progressive approach led to international recognition and roles in companies willing to challenge the status quo and advance healthcare in important areas. In his role as CEO of Health Coach Systems International Inc. Mark continued his work through consulting on advancements in healthcare, augmenting human performance and mitigating and preventing preventable illness. This led to his study of medical cannabis and related technology. He subsequently became an investor in the Corporation and the CEO of Nanosphere Health Sciences Inc, an emerging publicly-traded nano-biotechnology company.
About Mark Ahrens-Townsend
Mr. Mark Ahrens-Townsend has spent over 35 years in the technology, engineering and venture capital industries. For the past 25 years, he has held senior executive roles and has served as President and CEO of three Canadian-based publicly traded companies specializing in information, communication and biotechnology. His business experience spans North America, Europe, and Asia. In addition, he has also served extensively on the boards and committees of several private and publicly held companies. Mr. Ahrens-Townsend holds a B.Sc. in Engineering and an MBA in Finance from the University of Manitoba.
About RavenQuest BioMed Inc.
RavenQuest is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development. RavenQuest is a licensed producer with facilities located in Markham, Ontario and Edmonton, Alberta.
RavenQuest maintains a research partnership with McGill University focused upon cultivar recognition, plant stabilization and yield maximization of the cannabis plant. The Company also focuses on partnerships with Indigenous communities.
For more information: https://rqbglobal.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
